Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140K Sell
5,829
-842
-13% -$22K 0.08% 214
2026
Q1
$187K Sell
6,671
-4,162
-38% -$111K 0.13% 120
2025
Q4
$270K Buy
10,833
+1,001
+10% +$25.2K 0.14% 124
2025
Q3
$251K Sell
9,832
-3,208
-25% -$79.2K 0.14% 137
2025
Q2
$316K Buy
13,040
+3,251
+33% +$75.8K 0.19% 63
2025
Q1
$248K Buy
9,789
+7,008
+252% +$183K 0.17% 91
2024
Q4
$74K Sell
2,781
-7,298
-72% -$198K 0.05% 683
2024
Q3
$292K Buy
10,079
+7,942
+372% +$232K 0.18% 62
2024
Q2
$60K Sell
2,137
-6,072
-74% -$167K 0.04% 779
2024
Q1
$228K Sell
8,209
-932
-10% -$25.9K 0.14% 125
2023
Q4
$263K Sell
9,141
-708
-7% -$21.4K 0.18% 66
2023
Q3
$326K Sell
9,849
-488
-5% -$17.3K 0.25% 39
2023
Q2
$379K Buy
10,337
+158
+2% +$6.15K 0.29% 30
2023
Q1
$415K Buy
10,179
+1,859
+22% +$80.3K 0.36% 20
2022
Q4
$426K Buy
8,320
+1,538
+23% +$73.7K 0.35% 27
2022
Q3
$297K Sell
6,782
-249
-4% -$12.1K 0.26% 39
2022
Q2
$368K Buy
7,031
+491
+8% +$25K 0.29% 37
2022
Q1
$339K Buy
6,540
+3,048
+87% +$158K 0.23% 49
2021
Q4
$206K Buy
+3,492
New +$173K 0.29% 26

Other funds holding PFE

Covestor's PFE Position: Q2 2026 in Review

Covestor reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $22K and leaving 5,829 shares worth $140K. The position accounts for 0.08% of the portfolio, ranked #214.

Covestor first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $426K in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Covestor held 5,829 shares of Pfizer worth $140K as of Q2 2026.
  • Covestor sold 842 Pfizer shares in Q2 2026, an estimated $22K.
  • Pfizer made up 0.08% of Covestor's portfolio in Q2 2026, its #214 holding.
  • Covestor first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Pfizer position peaked at $426K in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.